The international Ayurveda conference in Udupi, Karnataka, scheduled for September 29‑October 1, 2026, will spotlight the rising prevalence of autoimmune diseases. Experts will explore how Ayurvedic principles can complement modern immunology to address these complex conditions.
Key Takeaways
- International Ayurveda conference in Udupi from Sep 29 to Oct 1, 2026.
- Focus on autoimmune disorders with scientific sessions and workshops.
- Expected attendance of 1,500‑2,000 delegates.
Autoimmune diseases are emerging as one of the fastest‑growing public‑health challenges worldwide, prompting researchers to look beyond conventional treatments. In this context, the sixth International Conference on Translational Ayurveda in Autoimmune Disorders, “Kshamatvam 2026,” aims to bridge traditional wisdom with contemporary immunology.
The event will examine “translational Ayurveda,” a field that scrutinizes classical concepts such as vyādhikṣamatva (disease resistance), ojas (vital essence), bala (strength), agni (metabolism), prakṛti (constitution), and rasāyana therapies alongside modern insights into immune dysregulation and chronic inflammation.
Historical Background
While Ayurveda has been integrated with modern medicine for decades, its application to autoimmune conditions remains relatively unexplored. Over the past twenty years, Indian research institutes have conducted pilot clinical trials and genomic studies to assess Ayurveda’s role in modulating immune responses, laying the groundwork for this larger gathering.
Why This Matters
BozokMedia analysis shows that integrating Ayurvedic principles with contemporary immunology could unlock novel preventive and therapeutic strategies, especially as global incidence of diseases like rheumatoid arthritis and lupus rises.
"Combining modern immunology with Ayurvedic science offers a promising avenue to decode the complexity of autoimmune diseases," said Dr. Mamatha K.V., principal of SDMAHRC.
Frequently Asked Questions
Question 1: Are Ayurvedic treatments scientifically proven for autoimmune diseases?
Answer: Preliminary studies show encouraging results, but large‑scale clinical trials are still underway.
Question 2: Which international speakers will attend the conference?
Answer: Notable experts include Christian Kessler (Germany), Antonio Morandi (Italy) and Jorge Luis Berra (Argentina), among others.